Videos
Dana Goldman, PhD discusses the results of a Journal of the American Medical Association study analyzing the effects of cost increases in children's asthma medication.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Etentamig Clears the Bar Against Standard Therapy in Triple-Class Exposed Myeloma
2
MRD-Guided Transplant Deferral Remains Feasible at Nearly 4 Years in MILESTONE Study
3
Teclistamab-Daratumumab Intensification Achieves 73% MRD-Negative CR Rate in High-Risk Multiple Myeloma
4
FDA Approves Insulin Efsitora, Once-Weekly Basal Insulin Injection for Adults With T2D
5